Xelleratherapeutics - Latest News 2026-07-19T05:09:03+00:00 urn:uuid:b8d3e277-83ad-d1b9-4bcb-275aa435ef59 New Research Highlights the Critical Role of ATP in Human Health urn:uuid:65567788-0d1f-0179-4520-0757d93d536f 2026-02-11T06:31:27+00:00 Current Good Manufacturing Practice: Strengthening Quality and Trust in Modern Manufacturing urn:uuid:9eb96d46-6c5b-56b1-d335-8a36aa4abded 2025-12-19T05:14:37+00:00 Strengthening IP Protection to Safeguard Innovation in a Rapidly Evolving Global Market urn:uuid:4239fb9a-b07e-9e19-065b-6ba47a6599fd 2025-11-25T08:20:33+00:00 Advancing Precision in Drug Development: The Growing Importance of Bioanalytical Testing urn:uuid:f2326e74-e7fe-25c8-0cb0-1f4355556914 2025-10-17T05:07:31+00:00 Ensuring Quality and Safety: cGMP Standards Drive Excellence in Pharmaceutical Manufacturing urn:uuid:005a9174-810b-62ef-bb6b-579185ab1e7c 2025-09-25T11:45:46+00:00 Xellera Therapeutics enhances quality assurance with advanced release testing services urn:uuid:7904fd5f-0c4a-029b-4e1f-f67c420ded85 2025-08-21T06:20:59+00:00 Unveils Groundbreaking Advances in Cancer Treatment to Improve Patient Outcomes urn:uuid:c19d3b79-f4e6-6bf1-3702-1901d9eb3957 2025-07-14T07:19:55+00:00 Xellera Therapeutics Enhances Quality Control Capabilities to Strengthen Regulatory Compliance and Product Integrity urn:uuid:c87a588c-c1d7-c0cc-99ba-94cc68b5bb9a 2025-06-25T08:07:18+00:00